先聲藥業(02096.HK)斥4,231萬人民幣收購南京生產基地

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

先聲藥業(02096.HK)斥4,231萬人民幣收購南京生產基地

阿思達克 01-01 23:59

先聲藥業(02096.HK)公布關連交易，提前佈局規劃新的生產設施及倉儲場地，向江蘇診斷技術收購南京百家匯全部股權，其擁有一幅位於江蘇省南京市江北新區之工業用地，已用作建設製藥生產基地，現金代價4,231萬人民幣。

先聲藥業(02096.HK)

Relevant Stocks

先聲藥業(02096.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

先聲藥業(02096.HK)斥4,231萬人民幣收購南京生產基地

Services

About Us

Agreement Statement